MedTrace Logo

Exercise for Cognitive Excellence in Parkinson's Disease

NCT05720468 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-03-09

No results posted yet for this study

Summary

This study will evaluate the safety and feasibility of a home-based, virtually-supervised, combined high intensity endurance and resistance training program in people with Parkinson's disease. It will also evaluate the effects of exercise on cognition and underlying exercise-related biological markers (biomarkers).

Conditions

  • Parkinson Disease

Interventions

OTHER

Exercise

Combined endurance and resistance exercise training

OTHER

No Exercise

Continue usual level of physical activity; option to participate in exercise training program after 26-week intervention period

Sponsors & Collaborators

Principal Investigators

  • Nijee Luthra, MD, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-20
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05720468 on ClinicalTrials.gov